16:12 EST Inozyme files $300M mixed securities shelf
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on INZY:
- Inozyme Pharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights
- Inozyme reports Q3 EPS (29c), consensus (32c)
- Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Inozyme highlights inclusion of GACI in Genomics England’s Generation Study
- Inozyme Pharma Highlights Inclusion of Generalized Arterial Calcification of Infancy (GACI) in Genomics England’s Generation Study of Rare Conditions